Press Releases

View Archive: 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003

12.7.09
FibroGen, Inc., Reports Decision by USPTO Board of Patent Appeals and Interferences in the Company’s Favor

11.2.09
FibroGen Announces New Research in Anti-CTGF and HIF-PHI

6.15.09
FibroGen Begins Enrollment of Phase 2 Study of FG-3019, Monoclonal Antibody Against CTGF, in Patients with Diabetic Kidney Disease

2.3.09
FibroGen Announces New Research at Stanford University School of Medicine Indicates that Inhibiting CTGF Could Have Therapeutic Benefits in Treating Pancreatic Cancer

1.30.09
Patient Recruitment Resumes in FibroGen Phase 2 Study of Investigational Oral HIF-PH Inhibitor, FG-4592/ASP1517, for the Treatment of Anemia Associated with Chronic Kidney Disease